Table 1 Pre-treatment characteristics of the investigated patients
From: New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients
Stage 1 (n=14) | Stage 2 (n=71) | |
|---|---|---|
Demography | ||
Sex, F (n)* | 7 | 32 |
Age, years [mean ± SD]† | 37.1 [± 19.3] | 36.9 [± 15.8] |
Geographical origin | ||
Malawi, n | 3 | 27 |
Uganda, n | 11 | 44 |
CSF examinations | ||
Trypanosome positive, n | 0 | 64 |
WBC/μL (median, range) | 3 [2–5] | 21 [4–1140] |